427 related articles for article (PubMed ID: 10215637)
21. Metabolism of tauromustine in liver and lung microsomes from various species.
Tuvesson H; Gunnarsson PO; SeidegÄrd J
Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719
[TBL] [Abstract][Full Text] [Related]
22. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
Prueksaritanont T; Dwyer LM; Cribb AE
Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
[TBL] [Abstract][Full Text] [Related]
23. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate.
Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K
Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816
[TBL] [Abstract][Full Text] [Related]
24. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.
Smith G; Modi S; Pillai I; Lian LY; Sutcliffe MJ; Pritchard MP; Friedberg T; Roberts GC; Wolf CR
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):783-92. PubMed ID: 9560305
[TBL] [Abstract][Full Text] [Related]
25. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.
Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T
Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310
[TBL] [Abstract][Full Text] [Related]
26. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
Jacobson PA; Green K; Birnbaum A; Remmel RP
Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
[TBL] [Abstract][Full Text] [Related]
29. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
[TBL] [Abstract][Full Text] [Related]
30. Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase.
Satoh T; Fujita KI; Munakata H; Itoh S; Nakamura K; Kamataki T; Itoh S; Yoshizawa I
Anal Biochem; 2000 Nov; 286(2):179-86. PubMed ID: 11067738
[TBL] [Abstract][Full Text] [Related]
31. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
32. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of testosterone 6beta-hydroxylation in the reconstituted system with similar ratios of purified CYP3A4, NADPH-cytochrome p450 oxidoreductase and cytochrome B5 to human liver microsomes.
Taguchi M; Imaoka S; Yoshii K; Kobayashi K; Hosokawa M; Shimada N; Funae Y; Chiba K
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):53-63. PubMed ID: 11458985
[TBL] [Abstract][Full Text] [Related]
34. Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems.
Paine MJ; Gilham D; Roberts GC; Wolf CR
Arch Biochem Biophys; 1996 Apr; 328(1):143-50. PubMed ID: 8638923
[TBL] [Abstract][Full Text] [Related]
35. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.
Ren S; Yang JS; Kalhorn TF; Slattery JT
Cancer Res; 1997 Oct; 57(19):4229-35. PubMed ID: 9331082
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Supermix as an in vitro model of human liver microsomal drug metabolism.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
Biopharm Drug Dispos; 2002 Jul; 23(5):183-90. PubMed ID: 12116049
[TBL] [Abstract][Full Text] [Related]
37. Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates.
Mankowski DC; Lawton MP; Ekins S
Xenobiotica; 2000 Aug; 30(8):745-54. PubMed ID: 11037108
[TBL] [Abstract][Full Text] [Related]
38. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
Mankowski DC
Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]